As a combined abnormal inflammatory response with abnormal CH50 and C3 serum levels, without ocular inflammation or neoplastic diseases were documented in the first study, here we focused on risk alleles for AMD that involve different complement factors of the alternative complement pathway. The gene discussed is C3; the disease is neoplasm.